US-Russia nuclear treaty called START expired. Should we be worried? | The Excerpt

On Feb. 10, 2026 the US-Russia New START treaty expired, removing longstanding ceilings (previously 1,550 strategic warheads and 700 delivery systems) and leaving the two largest nuclear arsenals without quantitative limits for the first time since the early 1970s. Diplomatic prospects for a replacement are limited by the Russia–Ukraine war, US domestic politics, and China’s unwillingness to join three‑party talks; parallel risks include Iran’s roughly 400 kg of unverified highly enriched uranium, North Korea’s estimated ~100 weapons‑worth of fissile material, and renewed India–Pakistan escalation. For investors, the development increases geopolitical tail risk and may support defensive positioning (safe havens, certain defense suppliers) while immediate market-moving effects are uncertain.

Analysis

Market structure: Expiration of START increases the baseline geopolitical risk premium favoring defense primes (Lockheed LMT, Raytheon RTX, Northrop NOC), shipbuilders (HII), ISR/satcom suppliers (LHX, MAXAR?), uranium producers/ETF (CCJ, URA) and commodity exporters (oil). Expect backlog-driven revenue visibility to rise 10-30% for contractors over 12–36 months as procurement lead times lengthen and governments prefer onshore suppliers, lifting pricing power and margins while cyclical consumer sectors and EM assets face demand contraction and funding stress.

Risk assessment: Tail risks include a low-probability nuclear escalation (catastrophic market shock), regional wars (India–Pakistan, Korea) or sudden détente (policy reversal) that could flip trades; treat nuclear use as >1000x market-moving. Immediate (days): volatility/flows to Treasuries, gold, oil; short-term (weeks–months): defense rerating and EM underperformance; long-term (3–7 years): sustained defense capex but subject to US budget appropriations and congressional risk—track FY26–FY27 defense bill progress within 30–90 days.

Trade implications: Tactical: establish 2–3% long positions in LMT and RTX for 6–18 months and buy 6–12 month call spreads (e.g., LMT buy 1.0% notional 12-month 10–15% OTM call spread) to lever upside while limiting premium. Pair: long LMT (2%) / short DAL (1.5%) to express defense vs. travel demand divergence. Macro hedges: 1% GLD, 1% TLT (2–7yr IEI) for immediate safe-haven; buy 3–6 month puts on EEM (1% notional) to protect EM exposure.

Contrarian angles: Consensus may overstate China’s near-term contribution to a three-way arms race and underprice political constraints on US budget increases; defense re-rating could be underdone if multiple allies also step up procurement. Risks: political backlash, cost-overruns, and export-control frictions can cap upside—stagger sizing and scale into positions on 3–8% drawdowns, not all-in at first signal.

Key Decisions for Investors

• Initiate a 2.5% long position in Lockheed Martin (LMT) over the next 2–6 weeks; complement with a 6–12 month 10–15% OTM call spread sized at 25–33% of the equity position to capture upside from renewed procurement (target +15–25% upside, cut loss at -12%).
• Establish a 2% long in Raytheon Technologies (RTX) for 6–18 months to play missile/air-defense demand; hedge 20–30% of exposure with short-dated (3–6 month) puts if geopolitical headlines spike (IV > 50%).
• Execute a pair trade: long LMT (2%) and short Delta Air Lines (DAL) (1.5%) to express defense outperformance vs. commercial travel weakness; rebalance if DAL outperforming by >8% over a 30-day window.
• Allocate 1% to GLD and 1% to short-duration Treasuries (IEI or TLT duration 2–7yr) as immediate safe-haven hedges; trim both if VIX drops >30% from peak or if Congress passes a major détente/budget rollback within 90 days.
• Buy a 3–6 month put on EEM sized at 1% notional to protect EM downside; monitor three catalysts before adding risk: (a) US defense appropriations passing (30–90 days), (b) substantive Russia–US diplomatic signals (any week), (c) new North Korean/India–Pakistan tests (event-driven intraday).